Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.34.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.34.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
W.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
W.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.250ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.250ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.250ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.250NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.63ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.63NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.130ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.130ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.130ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.130NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.44ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.469ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.469ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.469ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.469NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used